Related Experiment Video

Updated: Aug 21, 2026

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

New paradigms, animal models may lift antidepressant research

David W Schulz

    Nature Medicine
    |November 2, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A New Method for Inducing a Depression-Like Behavior in Rats
    07:57

    A New Method for Inducing a Depression-Like Behavior in Rats

    Published on: February 22, 2018

    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
    07:13

    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

    Published on: October 24, 2018

    Related Experiment Videos

    Last Updated: Aug 21, 2026

    Animal Models of Depression - Chronic Despair Model (CDM)
    05:47

    Animal Models of Depression - Chronic Despair Model (CDM)

    Published on: September 23, 2021

    A New Method for Inducing a Depression-Like Behavior in Rats
    07:57

    A New Method for Inducing a Depression-Like Behavior in Rats

    Published on: February 22, 2018

    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
    07:13

    The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

    Published on: October 24, 2018

    Related Concept Videos

    Antidepressant Drugs: MAOIs and Other Agents01:23

    Antidepressant Drugs: MAOIs and Other Agents

    Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
    Antidepressant Drugs: Overview01:25

    Antidepressant Drugs: Overview

    Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

    Articles linked to this work by shared authors, journal, and citation graph.

    2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonists.

    Journal of medicinal chemistry·2008

    Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists.

    Journal of medicinal chemistry·2008

    3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.

    Bioorganic & medicinal chemistry letters·2005

    In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.

    Bioorganic & medicinal chemistry letters·2005

    Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.

    Journal of medicinal chemistry·2005

    Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.

    Synapse (New York, N.Y.)·2003

    Isthmin-2 is a first-trimester predictor of preeclampsia and fetal growth restriction.

    Nature medicine·2026

    Antifungal therapy improves microbiome dynamics in inflammatory bowel disease.

    Nature medicine·2026

    Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

    Nature medicine·2026

    Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium.

    Nature medicine·2026

    Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

    Nature medicine·2026

    Induced pluripotent stem cells from discovery to translation.

    Nature medicine·2026

    Validation of synthetic M-protein materials for external quality assessment: homogeneity, commutability, and stability.

    Clinical chemistry and laboratory medicine·2026

    Anti-amyloid treatment in Alzheimer disease: updated implications for patients with cerebral amyloid angiopathy and other cerebrovascular conditions.

    Frontiers in neurology·2026

    Microfluidic platform for nanoliter qPCR of several retinal pigment epithelial (RPE) cells.

    Journal of micromechanics and microengineering : structures, devices, and systems·2026

    Practical antimicrobial TDM (PAT) of vancomycin in Japanese emergency and critical care units: Concentration overestimation and correction using scaling factors.

    International journal of clinical pharmacology and therapeutics·2026

    LAD-NASH score using multiparametric ultrasound for identification of at-risk MASH: head-to-head comparison with the FAST score.

    Ultrasonography (Seoul, Korea)·2026

    Competitive SELEX Strategy for High-Affinity Aptamer Isolation and Enhanced Biosensing.

    Small (Weinheim an der Bergstrasse, Germany)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us